Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Dec
20
2024
 The Legal and Economic Realities of Medicare Drug Pricing: Navigating Opportunities and Challenges Sheppard, Mullin, Richter & Hampton LLP
Dec
20
2024
 GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List Foley & Lardner LLP
Dec
20
2024
 FDA To Publish Final Rule Defining “Healthy” Claims Keller and Heckman LLP
Dec
19
2024
 New Accelerated Approval Guidance Underscores Need for Accountability Sheppard, Mullin, Richter & Hampton LLP
Dec
19
2024
 FDA Finalizes "Healthy" Claims Rule Hunton Andrews Kurth
Dec
19
2024
 Ninth Circuit Precedent Limits Fraud-Based Label Claims Foley & Lardner LLP
Dec
19
2024
 First-Ever Corporate Integrity Agreement with Consulting Firm in Opioid Crisis-Related Resolution of Civil and Criminal Investigations Tycko & Zavareei LLP
Dec
19
2024
 The Best of Intentions: State Law Protections for Employee Cannabis Use May Not Protect Them After All Bradley Arant Boult Cummings LLP
Dec
19
2024
 The Grass May Not Be Greener in Texas: New Bill Seeks to Ban Hemp-Derived THC Products ArentFox Schiff LLP
Dec
19
2024
 Florida Employers Should Consider Accommodations for Off-Duty Use of Medical Marijuana, Court Rules Jackson Lewis P.C.
Dec
19
2024
 Factors Courts Commonly Consider When Deciding Motions to Transfer in ANDA Litigation Womble Bond Dickinson (US) LLP
Dec
19
2024
 The Devil Is in the Details: Bioequivalence, In Vitro Testing Not Enough to Establish Infringement McDermott Will & Emery
Dec
19
2024
 FDA Shares Testing Results for PFAS in Clams Keller and Heckman LLP
Dec
19
2024
 This Week in 340B: December 10 – 16, 2024 McDermott Will & Emery
Dec
18
2024
 FDA Targets GLP-1 Providers with Warning Letters Foley & Lardner LLP
Dec
18
2024
 National Association of Manufacturers Sends Letter to Trump Urging Regulatory Relief; Calls Out Food Traceability Rule Keller and Heckman LLP
Dec
18
2024
 November 2024 Bounty Hunter Plaintiff Claims Keller and Heckman LLP
Dec
18
2024
 AI in Drug Discovery: 2025 Outlook Foley & Lardner LLP
Dec
18
2024
 Three Overhauls to Accelerated Drug Approval You Need to Know About: Novel Endpoints, Confirmatory Trials, and Expedited Withdrawal of Approvals ArentFox Schiff LLP
Dec
18
2024
 Third Circuit Rules New Jersey Marijuana Law Lacks Private Right of Action to Enforce Employment Protections Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Dec
17
2024
 Preparation for 2024 Fiscal Year-End SEC Filings and 2025 Annual Shareholder Meetings Mintz
Dec
17
2024
 EPA Updates Recommendations of Specifications, Standards and Ecolabels for Federal Purchasing Bergeson & Campbell, P.C.
Dec
17
2024
 Private Equity: Senators Markey and Braun Seek Information on Role in Treatment for Opioid Use Disorder Foley & Lardner LLP
Dec
17
2024
 FDA Updates Guidance on Premarket Engagement for Genome-Edited Plant Varieties Keller and Heckman LLP
Dec
17
2024
 Drunk Driving Laws: Penalties and Legal Consequences for Offenders Buckfire Law
Dec
17
2024
 Unpacking Averages: Exploring Data on FDA’s Breakthrough Device Program Obtained Through FOIA Epstein Becker & Green, P.C.
Dec
17
2024
 Drug Test Woes: State Law Protections for Employee Cannabis Use May Not Protect Them After All Bradley Arant Boult Cummings LLP
Dec
16
2024
 EPA Issues Final SNURs for Multi-Walled Carbon Nanotubes (Generic) (P-21-216 and P-21-217) Bergeson & Campbell, P.C.
Displaying 1 - 28 of 11823
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins